GlassScriptPhysician profile
Michael S Haupert
NPI 1124018213
$3,163.15
in general payments reported to CMS, 2019-2025
16 companies · $549 in 2025
The $549 reported for 2025 was more than what 79% of Pediatric Otolaryngology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $632 · 2020: $130 · 2021: $269 · 2022: $563 · 2023: $582 · 2024: $438 · 2025: $549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,569.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,568.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $552.48 | 2022-2023 | Acclarent Navwire, Relieva Spinplus |
| Integra Lifesciences Corporation | $446.12 | 2024-2025 | Integra, Inspira Air, Acclarent Aera |
| Intersect Ent, INC. | $270.63 | 2019-2021 | |
| Stryker Corporation | $267.60 | 2020-2023 | Xpress Ent Dilation System |
| Optinose US, INC. | $239.22 | 2019-2021 | |
| Glaxosmithkline, LLC. | $215.80 | 2022-2023 | Nucala |
| Medtronic, INC. | $159.47 | 2024 | Stealthstation S8 Platform |
| Aerin Medical INC. | $149.16 | 2019 | |
| Becton, Dickinson and Company | $142.99 | 2019 | |
| Cochlear Americas | $133.12 | 2025 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Sanara Medtech INC. | $127.98 | 2024 | Celleraterx |
| Regeneron Healthcare Solutions, INC. | $121.84 | 2022 | |
| Ars Pharmaceuticals Operations, INC. | $120.04 | 2025 | Neffy |
| Ambu INC. | $117.42 | 2022 | |
| Medtronic USA, INC. | $70.81 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $28.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Haupert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.